HTR5A and metabolic dysfunction-associated steatohepatitis: Owaki et al. demonstrated that the autonomic liver–gut neural axis, particularly involving serotonin (5-HT) and its receptor HTR2A, plays a role in NASH: Blocking hepatic nerves reduced intestinal 5-HT, hepatic HTR2A expression, and lipogenic gene activity.